Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Insufficiency,Type 2 Diabetes”

334 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 334 results

Post-approval studies (Phase 4)Ended earlyNCT00936663
What this trial is testing

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

Who this might be right for
Type 2 DiabetesEnd Stage Renal Disease
University of Nebraska 3
Not applicableStudy completedNCT00237952
What this trial is testing

Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy

Who this might be right for
Diabetic NephropathiesDiabetes Mellitus, Type II
Chang Gung Memorial Hospital
Early research (Phase 1)UnknownNCT02467790
What this trial is testing

Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu Hansoh Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT02895750
What this trial is testing

Efficacity and Safety of Metformin XR in CKD Stage 1 to 3

Who this might be right for
Renal Insufficiency, Chronic
Centre Hospitalier Universitaire, Amiens 12
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Large-scale testing (Phase 3)WithdrawnNCT02015780
What this trial is testing

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Takeda
Not applicableStudy completedNCT05734989
What this trial is testing

Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD

Who this might be right for
Type 2 DiabetesChronic Kidney Diseases
Duke University 248
Large-scale testing (Phase 3)Study completedNCT00616811
What this trial is testing

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 148
Early research (Phase 1)UnknownNCT04221399
What this trial is testing

Type 2 Diabetes Patients With Renal Impairment

Who this might be right for
Type2 Diabetes
Daewoong Pharmaceutical Co. LTD. 35
Testing effectiveness (Phase 2)Study completedNCT01847092
What this trial is testing

A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Ardelyx 154
Large-scale testing (Phase 3)Study completedNCT01620489
What this trial is testing

Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 279
Early research (Phase 1)Study completedNCT01369602
What this trial is testing

Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532

Who this might be right for
Type 2 Diabetes MellitusHealthy
Pfizer 27
Post-approval studies (Phase 4)UnknownNCT05037695
What this trial is testing

SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI)

Who this might be right for
Diabetes Mellitus, Type 2Coronary Artery DiseaseAcute Kidney Injury
University of Sao Paulo General Hospital 40
Post-approval studies (Phase 4)UnknownNCT04485845
What this trial is testing

Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression

Who this might be right for
Metabolic SyndromeDiabete Type 2Kidney Insufficiency
Cairo University 39
Not applicableStudy completedNCT01729130
What this trial is testing

Adipose Tissue Function After Pancreas Transplantation

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1End Stage Renal Disease
The University of Texas Medical Branch, Galveston 15
Not applicableStudy completedNCT04791267
What this trial is testing

ENCOMPASS: Expansion Study C

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Chronic Kidney Diseases+4 more
University of Calgary 61
Large-scale testing (Phase 3)Study completedNCT01968044
What this trial is testing

A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)

Who this might be right for
Type 2 DM Patients With Moderate or Severe Renal Impairment
LG Life Sciences 132
Large-scale testing (Phase 3)Study completedNCT00509236
What this trial is testing

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)

Who this might be right for
Diabetes Mellitus, Type 2End-Stage Kidney Disease
Merck Sharp & Dohme LLC 129
Not applicableLooking for participantsNCT07360938
What this trial is testing

Drug Interaction Potential of Pro-Inflammatory Conditions

Who this might be right for
Diabetes Mellitus, Type 2End Stage Renal DiseaseIrritable Bowel Syndrome
Indiana University 150
Not applicableLooking for participantsNCT03549754
What this trial is testing

ICaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

Who this might be right for
Type 2 DiabetesHypertensionChronic Kidney Disease+1 more
AstraZeneca 35,000
Next Page